List view / Grid view
10 May 2016 | By Victoria White, Digital Content Producer
Researchers have described a potential new intraocular treatment that prevents and reverses some characteristics of diabetic retinopathy in a mouse model...
28 April 2016 | By Victoria White, Digital Content Producer
A new €2.25m US-Ireland R&D partnership has been set up to develop a gene therapy approach with the aim of potentially reversing diabetes-related blindness...
22 April 2016 | By SMi Group
SMI Reports (12.04.2016): MedImmune Senior Director for R&D to present keynote address on MED10382 at the 3rd Peptides Conference in London...
12 April 2016 | By Victoria White, Digital Content Producer
The result of their research is the production of hundreds of millions of lab-produced human beta cells that are able to relieve diabetes in mice...
11 April 2016 | By Victoria White, Digital Content Producer
New research could pave the way for a new generation of anti-diabetic drugs that are activated by the presence of either blue or ultra-violet light...
30 March 2016 | By Victoria White
Scientists have discovered two enzymes - AIG1 and ADTRP - that appear to play a role in metabolism and inflammation...
24 February 2016 | By Victoria White
Researchers have discovered that the protein cathelicidin antimicrobial peptide helps the pancreas regenerate and produce insulin...
19 February 2016 | By Victoria White
The discovery could change the way researchers understand and treat autoimmune diseases such as type 1 diabetes and multiple sclerosis...
11 February 2016 | By Victoria White
New research on the blood lipid-lowering protein FGF21 shows how it redistributes fatty acids by two distinct mechanisms...
23 December 2015 | By Victoria White
ARA 290 is a first-in-class synthetic peptide designed to activate the innate repair mechanism in the setting of tissue injury...
14 December 2015 | By Victoria White
A new study outlines a way of using antibiotic resistance to find chemicals capable of stopping amyloid formation in amyloid diseases such as Parkinson’s, Alzheimer’s and type II diabetes...
11 December 2015 | By Victoria White
A new study shows how different pharmaceutical drugs hit either the "on" or "off" switch of β2AR - signalling protein linked to asthma, obesity and type 2 diabetes...
26 November 2015 | By Victoria White
Venom Knowledge Base summarises the results of 5,117 studies in the medical literature describing the use of venom toxins as painkillers and as treatments for diseases...
26 November 2015 | By Victoria White
Scientists from the University of Toronto have switched off, one by one, almost 18,000 genes - 90% of the entire human genome - to find the genes that are essential for cell survival...
16 November 2015 | By Victoria White
Investigators found that a protein called SIRT3 provides resistance to obesity-related inflammatory response...
